Judges Scientific Regulatory News (JDG)

Judges Scientific plc (the "Company")

Directors' Interests and Grants of Options

10 May 2011

The Company announces that, on 9 May 2011, it granted options over an aggregate of 51,000 new Ordinary Shares of 5p each in the capital of the Company ("Ordinary Shares"), comprising options over 22,500 new Ordinary Shares under the Company's Approved Plan and options over 28,500 new Ordinary Shares under the Company's Unapproved Plan. These are all exercisable between three and ten years from the date of grant at an exercise price of £4.70 per share.

Included in these figures are options over 5,000 shares under the Unapproved Plan which were granted to Ralph Cohen, Finance Director of the Company. As a result, he now holds options over 72,000 new Ordinary Shares, comprising 28,900 under the Approved Plan and 43,100 under the Unapproved Plan. Also included are options granted to David Barnbrook, a Director and the Chief Operating Officer of the Company, over 5,000 new Ordinary Shares under the Unapproved Plan. As a result, he now holds options over 55,000 new Ordinary Shares, comprising 28,450 under the Approved Plan and 26,550 under the Unapproved Plan. The new options granted to these two directors will vest on achievement of future earnings per share targets.

Ends

Enquiries:

Judges Scientific plc

David Cicurel, CEO

01342 323 600

Shore Capital

Pascal Keane

020 7408 4090

Cardew Group

Melvyn Marckus

07775 896491